Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5171537
Max Phase: Preclinical
Molecular Formula: C72H92N8O5
Molecular Weight: 1149.58
Associated Items:
ID: ALA5171537
Max Phase: Preclinical
Molecular Formula: C72H92N8O5
Molecular Weight: 1149.58
Associated Items:
Canonical SMILES: O[C@H]1CCN[C@]2(C[C@]34CN5CCCC/C=C/CC[C@](O)(C=C(C6=NC=CC7c8ccccc8NC67)[C@@H]3CC5)C4)CC[C@H]1OC13CCCC(CCN1[C@@H]1[C@]4(CN5CCCC/C=C\CC[C@]1(O)C=C(c1nccc6c1[nH]c1ccccc16)[C@@H]4CC5)C3)O2
Standard InChI: InChI=1S/C72H92N8O5/c81-60-26-36-75-71(45-67-44-68(82)30-13-5-1-3-7-15-37-78(47-67)39-28-56(67)54(42-68)62-64-52(24-34-73-62)50-19-9-11-21-58(50)76-64)33-23-61(60)85-72-32-17-18-49(84-71)27-41-80(72)66-69(46-72)48-79-38-16-8-4-2-6-14-31-70(66,83)43-55(57(69)29-40-79)63-65-53(25-35-74-63)51-20-10-12-22-59(51)77-65/h1-2,5-6,9-12,19-22,24-25,34-35,42-43,49,52,56-57,60-61,64,66,75-77,81-83H,3-4,7-8,13-18,23,26-33,36-41,44-48H2/b5-1+,6-2-/t49?,52?,56-,57-,60-,61+,64?,66+,67+,68-,69-,70-,71+,72?/m0/s1
Standard InChI Key: SQTUMUCDPKCJBE-SWMFMNTESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1149.58 | Molecular Weight (Monoisotopic): 1148.7191 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Aaghaz S, Sharma K, Jain R, Kamal A.. (2021) β-Carbolines as potential anticancer agents., 216 [PMID:33684825] [10.1016/j.ejmech.2021.113321] |
Source(1):